Skip to content
DEALDATABASEby Legal Desire
31 May 2023

Freshfields Advises SERB Pharmaceuticals on its U.S. Partnership with SFJ Pharmaceuticals

Advising firms

Deal team

19 lawyers named
LawyerFirmSeniorityPracticeOffice
Adam Golden Lead Freshfields Partner Not stated Not stated
Jeff Jay Freshfields Counsel Not stated Not stated
Philipp Lehmann Freshfields Counsel Not stated Not stated
Tanny Kang Freshfields Associate Not stated Not stated
Paul Humphreys Freshfields Partner Not stated Not stated
Madlyn Primoff Freshfields Partner Not stated Not stated
Samantha Braunstein Freshfields Counsel Not stated Not stated
Richard Daniels Freshfields Counsel Not stated Not stated
Lacey Nemergut Freshfields Senior associate Not stated Not stated
Alex Rich Freshfields Senior associate Not stated Not stated
Sora Park Freshfields Associate Not stated Not stated
Kelsey Pepper Freshfields Associate Not stated Not stated
Anne Powderly Freshfields Associate Not stated Not stated
Isabella Shaulis Freshfields Associate Not stated Not stated
Jake Silvers Freshfields Associate Not stated Not stated
Mary Lehner Freshfields Partner antitrust Not stated
Meytal McCoy Freshfields Counsel antitrust Not stated
Charles Ramsey Freshfields Counsel antitrust Not stated
Elizabeth Giordano Freshfields Associate antitrust Not stated

Stated terms

Stated value
Not stated
What the figure measures
Not stated
Client
SERB PharmaceuticalsBuy-side
Counterparties
SFJ Pharmaceuticals (Sell-side)